{"id":"W2697574135","doi":"10.1111/bjd.15750","title":"Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase <scp>III NAVIGATE</scp> trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":339,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Janssen Research and Development","keywords":"Ustekinumab; Medicine; Psoriasis; Double blind; Dermatology; Randomized controlled trial; Randomization; Internal medicine; Alternative medicine; Disease; Pathology; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001334613,0.0002483705,0.001537131,0.000249471,0.0003056873,0.00004362991,0.0006267794,0.0003586945,0.000007046202],"category_scores_gemma":[0.001695083,0.0001885499,0.0002138777,0.0001203279,0.0006738748,0.0002669844,0.0001419337,0.0003694122,0.000002525986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003840208,"about_ca_system_score_gemma":0.0002163327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003627648,"about_ca_topic_score_gemma":0.0003485457,"domain_scores_codex":[0.9957522,0.001954383,0.001498305,0.0002902902,0.0001345216,0.0003702877],"domain_scores_gemma":[0.9958613,0.001199784,0.001988359,0.0005068669,0.0003612385,0.00008244854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9725189,0.001159757,0.003658433,0.00001588505,0.0006645664,0.000225904,0.001440205,0.000008222095,0.0005298173,0.00001968674,0.0002805899,0.019478],"study_design_scores_gemma":[0.9260177,0.001628965,0.05132594,0.0004848672,0.0004221998,0.002068545,0.0002022857,0.000001170237,0.01722045,0.00002775305,0.0004998923,0.0001002437],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996523,0.0009675059,0.00001769008,0.0002671234,0.0006196022,0.001313124,0.0001713079,0.000005424572,0.0001152133],"genre_scores_gemma":[0.9993812,0.0002844869,0.00006718517,0.0000272639,0.00003387778,0.00002035069,0.00002806033,0.00002128539,0.0001362828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04766751,"threshold_uncertainty_score":0.7688841,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01798615141328034,"score_gpt":0.2754203383737347,"score_spread":0.2574341869604543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}